Author Archives: Paul Older

Comparison of Methods for the Estimation of the Maximum Oxygen Uptake of Men Drug Addicts.

Wang K; Jiang H; Zhang T; Yin L; Chen X; Luo J;

Frontiers in physiology [Front Physiol] 2021 Sep 10; Vol. 12, pp. 683942.
Date of Electronic Publication: 2021 Sep 10 (Print Publication: 2021).

Background: Maximum oxygen uptake (VO 2max ) is an important respiratory physiological index of the aerobic endurance of the body, especially for special groups such as drug addicts, and it is an important indicator for assessing the cardiopulmonary function and formulating exercise prescriptions. Although the cardiopulmonary exercise test (CPX) is a classic method to directly measure VO 2max , this method is limited by factors such as cumbersome operating procedures and expensive equipment, resulting in its relatively low applicability. Recently, many studies have begun to focus on the estimation of VO 2max in different groups of people, but few studies have focused on drug addicts.
Methods: Fifteen chemically synthesized drug addicts (such as amphetamines) and Fifteen plant-derived drug addicts (such as heroin) were recruited at the Chongqing Compulsory Isolation and Drug Rehabilitation Center in China. First, the VO 2max of subjects was directly measured through the CPX. Second, after subjects were fully rested, they were required to complete the 30-s high-leg raise, 1,000-m walk, and 3-min step experiment. Finally, SPSS 21.0 software was used to perform the correlation and linear regression analysis to verify the estimated effectiveness.
Results: (1) Regardless of chemically synthesized or natural plant-derived drug addicts, the years of drug use and walking time of 1,000 m were significantly negatively correlated with VO 2max (chemically synthesized: P < 0.01 and natural plant-derived: P < 0.05), the number of 30-s high-leg raises was a significantly positive correlation with VO 2max ( P < 0.05 and P < 0.01), and the 3-min step index was significantly positively correlated with VO 2max ( P < 0.01 and P < 0.01). (2) Regression analysis shows that the 30-s high-leg lift, 1,000-m walking, and 3-min step experiment could effectively estimate the VO 2max of chemically synthesized and natural plant-derived drug addicts. (3) Multiple linear regression constructed by the years of drug use combined with the step index has the highest estimated accuracy for the VO 2max of chemically synthesized drug addicts (96.48%), while the unary regression equation established by a single step index has the highest prediction accuracy for the VO 2max of natural plant-derived addicts (94.30%).
Conclusion: The indirect measurement method could effectively estimate the VO 2max of drug addicts, but different measurement methods have certain differences in the estimation accuracy of VO 2max of different drug addicts. In the future, the physical characteristics of drug users can be fully considered, combined with more cutting-edge science and technology, to make the estimation accuracy of VO 2max closer to the real level.

Correlation of anthropometric index and cardiopulmonary exercise testing in children with pectus excavatum.

Oleksak F; Spakova B; Durdikova A; Durdik P; Kralova T; Igaz M; Molnar M;Gura M; Murgas D;

Respiratory physiology & neurobiology [Respir Physiol Neurobiol] 2021 Sep 21; Vol. 296, pp. 103790.
Date of Electronic Publication: 2021 Sep 21.

Background: Cardiopulmonary exercise testing (CPET) is a method used to evaluate functional impairment of patients with various diseases.
Objective: The objective was to use CPET to estimate the usability of anthropometric index (AI) in patients with pectus excavatum (PE) as a marker of functional impairment caused by chest deformity.
Methods: The study included 32 paediatric patients (28 males) with PE. Patients underwent CPET using a breath-by-breath exhaled gas analysis method and continuous monitoring of cardiac parameters.
Results: In both groups, two (overall four) patients met criteria for cardiogenic limitation (low VO 2 and low O 2 Pulse). Mean VO 2 /WR was below two standard deviations (2SD) in patients with less severe PE; other observed parameters were within normal limits (Z-score ± 2 SD). The AI had no observed correlation with peak ventilation, VO 2 peak and peak workload.
Conclusion: The obtained CPET data do not correlate well with the severity of chest deformity expressed with AI. There were similar physical activity limitations in both examined groups of patients and they did not depend on the severity of the deformity.

Rest and exercise oxygen uptake and cardiac output changes 6 months after successful transcatheter mitral valve repair.

Vignati C; De Martino F; Muratori M; Salvioni E; Tamborini G; Bartorelli A; Pepi M; Alamanni F; Farina S;
Cattadori G;Mantegazza V; Agostoni P;

ESC heart failure [ESC Heart Fail] 2021 Sep 22. Date of Electronic Publication: 2021 Sep 22.

Aims: Changes in peak exercise oxygen uptake (VO 2 ) and cardiac output (CO) 6 months after successful percutaneous edge-to-edge mitral valve repair (pMVR) in severe primary (PMR) and functional mitral regurgitation (FMR) patients are unknown. The aim of the study was to assess the efficacy of pMVR at rest by echocardiography, VO 2 and CO (inert gas rebreathing) measurement and during cardiopulmonary exercise test with CO measurement.
Methods and Results: We evaluated 145 and 115 patients at rest and 98 and 66 during exercise before and after pMVR, respectively. After successful pMVR, significant reductions in MR and NYHA class were observed in FMR and PMR patients. Cardiac ultrasound showed reverse remodelling (left ventricular end-diastolic volume from 158 ± 63 mL to 147 ± 64, P < 0.001; ejection fraction from 51 ± 15 to 48 ± 14, P < 0.001; pulmonary artery systolic pressure (PASP) from 43 ± 13 to 38 ± 8 mmHg, P < 0.001) in the entire population. These changes were significant in PMR (n = 62) and a trend in FMR (n = 53), except for PASP, which decreased in both groups. At rest, CO and stroke volume (SV) increased in FMR with a concomitant reduction in arteriovenous O 2 content difference [ΔC(a-v)O 2 ]. Peak exercise, CO and SV increased significantly in both groups (CO from 5.5 ± 1.4 L/min to 6.3 ± 1.5 and from 6.2 ± 2.4 to 6.7 ± 2.0, SV from 57 ± 19 mL to 66 ± 20 and from 62 ± 20 to 69 ± 20, in FMR and PMR, respectively), whereas peak VO 2 was unchanged and ΔC(a-v)O 2 decreased.
Conclusions: These data confirm pMVR-induced clinical improvement and reverse ventricular remodelling at a 6-month analysis and show, in spite of an increase in CO, an unchanged exercise performance, which is achieved through a ‘more physiological’ blood flow distribution and O 2 extraction behaviour. Direct rest and exercise CO should be measured to assess pMVR efficacy.

Sub-maximal aerobic exercise training reduces hematocrit and ameliorates symptoms in Andean highlanders with Chronic Mountain Sickness.

Macarlupú JL; Vizcardo-Galindo G; Figueroa-Mujíca R; Voituron N; Richalet JP; Villafuerte FC;

Experimental physiology [Exp Physiol] 2021 Sep 23. Date of Electronic Publication: 2021 Sep 23.

New Findings: What is the central question of this study? What is the effect of sub-maximal aerobic exercise training on signs and symptoms of chronic mountain sickness (CMS) in Andean highlanders? What is the main finding and its importance? Aerobic exercise training effectively reduces hematocrit, ameliorates symptoms, and improves aerobic capacity in CMS patients, suggesting that a regular aerobic exercise training program might be used as a low-cost non-invasive/non-pharmacological management strategy of this syndrome.
Abstract: Excessive erythrocytosis (EE) is the hallmark sign of Chronic Mountain Sickness (CMS), a debilitating syndrome associated with neurological symptoms and increased cardiovascular risk. We have shown that unlike sedentary residents at the same altitude, trained individuals maintain hematocrit within sea-level range, and thus we hypothesize that aerobic exercise training (ET) might reduce excessive hematocrit and ameliorate CMS signs and symptoms. Eight highlander men (38 ± 12y) with CMS (hematocrit: 70.6 ± 1.9%, CMS score: 8.8 ± 1.4) from Cerro de Pasco-Peru (4340m) participated in the study. Baseline assessment included hematocrit, CMS score, pulse oximetry, maximal cardiopulmonary exercise testing, and in-office plus 24h ambulatory blood pressure (BP) monitoring. Blood samples were collected to assess erythropoietic, hemolysis, and cardiometabolic markers. ET consisted of pedaling exercise in a cycloergometer at 60% of VO 2peak for 1h/day, 4 days/week for 8 weeks, and participants were assessed at weeks 4 and 8. Hematocrit and CMS score decreased significantly by week 8 (to 65.6 ± 6.6%, and 3.5 ± 0.8, respectively, p<0.05), while VO 2peak and maximum workload increased with ET (33.8 ± 2.4 vs. 37.2 ± 2.0ml/min/kg, p<0.05; and 172.5 ± 9.4 vs 210.0 ± 27.8W, p<0.01; respectively). Except for an increase in HDL-C, other blood markers and BP showed no differences. Our results suggest that reduction of hematocrit and CMS symptoms result mainly from hemodilution due to plasma volume expansion rather than to hemolysis. In conclusion, we show that ET can effectively reduce hematocrit, ameliorate symptoms, and improve aerobic capacity in CMS patients, suggesting that regular aerobic exercise might be used as a low-cost non-invasive/non-pharmacological management strategy.

Is the modified shuttle test a maximal effort test in children and adolescents with asthma?

Reimberg MM; Ritti-Dias R; Selman JP; Scalco RS; Wandalsen GF; Solé D; Hulzebos HJ; Takken T; Corso SD;
Lanza FC;

Pediatric pulmonology [Pediatr Pulmonol] 2021 Sep 27. Date of Electronic Publication: 2021 Sep 27.

Purpose: Whether modified shuttle teste (MST) achieves maximal effort in children and adolescents with asthma is unclear. The aim was to compare the physiological responses of MST to the cardiopulmonary exercise test (CPET) in pediatric patients with asthma, to observe its convergent validity.
Patients and Methods: cross sectional study, volunteers with asthma (6 to 17 years of age) under regular treatment. The MST is an external-paced test, and the participants were allowed to walk/run. CPET was performed on a cycle ergometer to compare with MST. Gas exchange (VO 2 , VCO 2 , and VE) and heart rate (HR) were the outcomes, and continuously assessed in both tests.
Results: 47 volunteers were included, normal lung function FEV1/FVC 88.6 (7.7). VO 2peak was higher at MST (2.0 ± 0.6 L/min) compared to CPET (1.6 ± 0.5 L/min), p< 0.001. Similar to VE at MST (50 ± 16 L/min) vs at CPET (40 ± 13 L/min), and VCO 2 , at MST (2.1 ± 0.8 L/min) vs CPET (1.7 ± 0.6 L/min), p < 0.001. HR was also higher at MST (94 ± 6%pred) vs CPET (87 ± 8%pred), p=0.002. VO 2peak in MST correlated to the CPET (r = 0.78, p < 0.001). The ICC of VO 2peak between tests was 0.73 (0.06 – 0.89), p<0.001, and VO2peak Bland-Altman analysis showed bias of 0.46L/min.
Conclusion: the MST showed maximal physiologic response in children and adolescents with asthma. It is valid test, and can be used as an alternative to evaluate exercise capacity.

Does Becoming Fit Mean Feeling (f)it? A Comparison of Physiological and Experiential Fitness Data From the iReAct Study.

Gropper H; Mattioni Maturana F; Nieß AM; Thiel A;

Frontiers in sports and active living [Front Sports Act Living] 2021 Sep 01; Vol. 3, pp. 729090.
Date of Electronic Publication: 2021 Sep 01 (Print Publication: 2021).

Regular exercise fosters fitness-enhancing benefits. We assume that exercise interventions become successful and sustainable if physiological benefits of exercise are also subjectively perceivable. The goal of this study was to examine how young inactive adults physiologically respond to an exercise intervention and how those responses are subjectively experienced . Furthermore, we aimed to assess whether the sequence of two distinct endurance-based exercise modes has an impact on physiological and subjectively experienced physical fitness. Thirty-one young inactive adults were assessed for this substudy of the larger iReAct study. Participants were randomly assigned to a high-intensity interval training (HIIT) or a moderate-intensity continuous training (MICT) group for 6 weeks and subsequently switched groups for a second training period. Physiological fitness data was collected at baseline, follow-up I, and follow-up II using a graded cardiopulmonary exercise test. Subjectively reconstructed (i.e., retrospective constructions) experiences relating to physical fitness were assessed at follow-up II using a biographical mapping method. A repeated-measures one-way ANOVA on each training group was performed to see whether physiological and subjectively experienced fitness differed across training periods. The rate of change between all variables was calculated for the first and the second training period in order to compare the agreement between physiological and subjective fitness improvements. Participants increased their fitness across the intervention period both physiologically and subjectively. However, the rate of change depended on the sequence of the two training modes. While VO 2max increased significantly in both training periods in the MICT-HIIT sequence, a significant increase in VO 2max in the HIIT-MICT sequence was only observed in the HIIT period. Participants similarly perceived those increases subjectively in their exercise-related physical fitness, although they experienced a significant decrease in the second period of the HIIT-MICT sequence. For subjectively perceived physical fitness relating to everyday activities, significant increases were only observed for the first period of the MICT-HIIT sequence. Young inactive adults can improve both their physiological and their subjectively perceived fitness through regular exercise. However, exercise modes and their sequence can make a substantial difference regarding measured and perceived physical fitness. Additionally, despite a favorable tendency toward HIIT over MICT, inter- and intra-individual variability, particularly in the subjective experiences of fitness, reiterates the necessity of individualized approaches to exercise.

Exploring the Anthropometric, Cardiorespiratory, and Haematological Determinants of Marathon Performance.

Christou GA; Pagourelias ED; Deligiannis AP; Kouidi EJ;

Frontiers in physiology [Front Physiol] 2021 Sep 03; Vol. 12, pp. 693733.
Date of Electronic Publication: 2021 Sep 03 (Print Publication: 2021).

Aim: We aimed to investigate the main anthropometric, cardiorespiratory and haematological factors that can determine marathon race performance in marathon runners.
Methods: Forty-five marathon runners (36 males, age: 42 ± 10 years) were examined during the training period for a marathon race. Assessment of training characteristics, anthropometric measurements, including height, body weight ( n = 45) and body fat percentage (BF%) ( n = 33), echocardiographic study ( n = 45), cardiopulmonary exercise testing using treadmill ergometer ( n = 33) and blood test ( n = 24) were performed. We evaluated the relationships of these measurements with the personal best marathon race time (MRT) within a time frame of one year before or after the evaluation of each athlete.
Results: The training age regarding long-distance running was 9 ± 7 years. Training volume was 70 (50-175) km/week. MRT was 4:02:53 ± 00:50:20 h. The MRT was positively associated with BF% ( r = 0.587, p = 0.001). Among echocardiographic parameters, MRT correlated negatively with right ventricular end-diastolic area (RVEDA) ( r = -0.716, p < 0.001). RVEDA was the only independent echocardiographic predictor of MRT. With regard to respiratory parameters, MRT correlated negatively with maximum minute ventilation indexed to body surface area (VEmax/BSA) ( r = -0.509, p = 0.003). Among parameters of blood test, MRT correlated negatively with haemoglobin concentration ( r = -0.471, p = 0.027) and estimated haemoglobin mass (Hbmass) ( r = -0.680, p = 0.002). After performing multivariate linear regression analysis with MRT as dependent variable and BF% (standardised β = 0.501, p = 0.021), RVEDA (standardised β = -0.633, p = 0.003), VEmax/BSA (standardised β = 0.266, p = 0.303) and Hbmass (standardised β = -0.308, p = 0.066) as independent variables, only BF% and RVEDA were significant independent predictors of MRT (adjusted R 2 = 0.796, p < 0.001 for the model).
Conclusions: The main physiological determinants of better marathon performance appear to be low BF% and RV enlargement. Upregulation of both maximum minute ventilation during exercise and haemoglobin mass may have a weaker effect to enhance marathon performance.

Minute ventilation/carbon dioxide production in congenital heart disease.

Hager A;

European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2021 Sep 15; Vol. 30 (161). Date of Electronic Publication: 2021 Sep 15 (Print Publication: 2021).

This review summarises various applications of how ventilatory equivalent (ventilatory efficiency or better still ventilatory inefficiency) and the minute ventilation ( VE )/carbon dioxide production ( VCO 2 ) slope obtained from cardiopulmonary exercise testing (CPET) can be used in the diagnostic or prognostic workup of patients with congenital heart disease.The field of congenital heart disease comprises not only a very heterogeneous patient group with various heart diseases, but also various conditions in different stages of repair, as well as the different residuals seen in long-term follow-up. As such, various physiologic disarrangements must be considered in the analysis of increased VE / VCO 2 slope from CPET in patients with congenital heart disease. In addition to congestive heart failure (CHF), cyanosis, unilateral pulmonary stenosis and pulmonary hypertension (PH) provide the background for this finding. The predictive value of increased VE / VCO 2 slope on prognosis seems to be more important in conditions where circulatory failure is associated with failure of the systemic ventricle. In cyanotic patients, those with Fontan circulation, or those with substantial mortality from arrhythmia, the impact of VE / VCO 2 on prognosis is not that important.

Cardiopulmonary Exercise Test in the Detection of Unexplained Post-COVID-19 Dyspnea.

Djokovic D; Nikolic M; Muric N; Nedeljkovic I;Simovic S; Novkovic L; Cupurdija V; Savovic Z; Vuckovic-Filipovic J; Susa R; Cekerevac I;

International heart journal [Int Heart J] 2021 Sep 17. Date of Electronic Publication: 2021 Sep 17.

There is emerging evidence of prolonged recovery in survivors of coronavirus disease 2019 (COVID-19), even in those with mild COVID-19. In this paper, we report a case of a 39-year-old male with excessive body weight and a history of borderline values of arterial hypertension without therapy, who was mainly complaining of progressive dyspnea after being diagnosed with mild COVID-19. According to the recent guidelines on the holistic assessment and management of patients who had COVID-19, all preferred diagnostic procedures, including multidetector computed tomography (CT), CT pulmonary angiogram, and echocardiography, should be conducted. However, in our patient, no underlying cardiopulmonary disorder has been established. Therefore, considering all additional symptoms our patient had beyond dyspnea, our initial differential diagnosis included anxiety-related dysfunctional breathing. However, psychiatric evaluation revealed that our patient had only a mild anxiety level, which was unlikely to provoke somatic complaints. We decided to perform further investigations considering that cardiopulmonary exercise test (CPET) represents a reliable diagnostic tool for patients with unexplained dyspnea. Finally, the CPET elucidated the diastolic dysfunction of the left ventricle, which was the most probable cause of progressive dyspnea in our patient. We suggested that, based on uncontrolled cardiovascular risk factors our patient had, COVID-19 triggered a subclinical form of heart failure (HF) with preserved ejection fraction (HFpEF) to become clinically manifest. Recently, the new onset, exacerbation, or transition from subclinical to clinical HFpEF has been associated with COVID-19. Therefore, in addition to the present literature, our case should warn physicians on HFpEF among survivors of COVID-19.